Compile Data Set for Download or QSAR
Report error Found 205 Enz. Inhib. hit(s) with all data for entry = 502
TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3183(2-({2,6-dihydroxy-4-[({2-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 0.600nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3183(2-({2,6-dihydroxy-4-[({2-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 0.900nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3186(2-[(4-{[(2S)-2-benzenesulfonamido-3-(4-hydroxyphen...)
Affinity DataIC50: 3nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3186(2-[(4-{[(2S)-2-benzenesulfonamido-3-(4-hydroxyphen...)
Affinity DataIC50: 3nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3149(Acyclic Balanol Analog (-)-1 | 2-{[2,6-dihydroxy-4...)
Affinity DataIC50: 3nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3199(2-{[2,6-dihydroxy-4-({[(1R,2S)-2-[(4-hydroxyphenyl...)
Affinity DataIC50: 3nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3199(2-{[2,6-dihydroxy-4-({[(1R,2S)-2-[(4-hydroxyphenyl...)
Affinity DataIC50: 3nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3199(2-{[2,6-dihydroxy-4-({[(1R,2S)-2-[(4-hydroxyphenyl...)
Affinity DataIC50: 4nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3199(2-{[2,6-dihydroxy-4-({[(1R,2S)-2-[(4-hydroxyphenyl...)
Affinity DataIC50: 5nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 5nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3186(2-[(4-{[(2S)-2-benzenesulfonamido-3-(4-hydroxyphen...)
Affinity DataIC50: 7nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C gamma type(Human)
Sphinx Laboratories

LigandPNGBDBM3183(2-({2,6-dihydroxy-4-[({2-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3149(Acyclic Balanol Analog (-)-1 | 2-{[2,6-dihydroxy-4...)
Affinity DataIC50: 10nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3149(Acyclic Balanol Analog (-)-1 | 2-{[2,6-dihydroxy-4...)
Affinity DataIC50: 10nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C gamma type(Human)
Sphinx Laboratories

LigandPNGBDBM3149(Acyclic Balanol Analog (-)-1 | 2-{[2,6-dihydroxy-4...)
Affinity DataIC50: 10nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 10nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3200(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-[(4-hydroxyphenyl...)
Affinity DataIC50: 10nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 10nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3184(2-{[2,6-dihydroxy-4-({[(3R,4R)-3-[(4-hydroxybenzen...)
Affinity DataIC50: 20nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3182(CHEMBL49354 | 2-({2,6-dihydroxy-4-[({3-[(4-hydroxy...)
Affinity DataIC50: 20nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3187(2-[(4-{[(2R)-2-benzenesulfonamido-3-(4-hydroxyphen...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3185((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-2-...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3187(2-[(4-{[(2R)-2-benzenesulfonamido-3-(4-hydroxyphen...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3149(Acyclic Balanol Analog (-)-1 | 2-{[2,6-dihydroxy-4...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C epsilon type(Human)
Sphinx Laboratories

LigandPNGBDBM3149(Acyclic Balanol Analog (-)-1 | 2-{[2,6-dihydroxy-4...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3193((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-1-...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3200(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-[(4-hydroxyphenyl...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3200(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-[(4-hydroxyphenyl...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3182(CHEMBL49354 | 2-({2,6-dihydroxy-4-[({3-[(4-hydroxy...)
Affinity DataIC50: 23nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3182(CHEMBL49354 | 2-({2,6-dihydroxy-4-[({3-[(4-hydroxy...)
Affinity DataIC50: 30nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3182(CHEMBL49354 | 2-({2,6-dihydroxy-4-[({3-[(4-hydroxy...)
Affinity DataIC50: 30nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C gamma type(Human)
Sphinx Laboratories

LigandPNGBDBM3182(CHEMBL49354 | 2-({2,6-dihydroxy-4-[({3-[(4-hydroxy...)
Affinity DataIC50: 30nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
LigandPNGBDBM3183(2-({2,6-dihydroxy-4-[({2-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 30nMpH: 7.5 T: 2°CAssay Description:The activity of PKA, activated by cAMP, is measured by its ability to transfer phosphate from [gamma-32P]ATP to histone.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3186(2-[(4-{[(2S)-2-benzenesulfonamido-3-(4-hydroxyphen...)
Affinity DataIC50: 30nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3185((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-2-...)
Affinity DataIC50: 30nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3187(2-[(4-{[(2R)-2-benzenesulfonamido-3-(4-hydroxyphen...)
Affinity DataIC50: 30nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C alpha type(Human)
Sphinx Laboratories

LigandPNGBDBM3149(Acyclic Balanol Analog (-)-1 | 2-{[2,6-dihydroxy-4...)
Affinity DataIC50: 30nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3193((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-1-...)
Affinity DataIC50: 30nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3193((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-1-...)
Affinity DataIC50: 30nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C alpha type(Human)
Sphinx Laboratories

LigandPNGBDBM3199(2-{[2,6-dihydroxy-4-({[(1R,2S)-2-[(4-hydroxyphenyl...)
Affinity DataIC50: 30nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 30nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3200(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-[(4-hydroxyphenyl...)
Affinity DataIC50: 30nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C epsilon type(Human)
Sphinx Laboratories

LigandPNGBDBM3182(CHEMBL49354 | 2-({2,6-dihydroxy-4-[({3-[(4-hydroxy...)
Affinity DataIC50: 38nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C alpha type(Human)
Sphinx Laboratories

LigandPNGBDBM3183(2-({2,6-dihydroxy-4-[({2-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 40nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3183(2-({2,6-dihydroxy-4-[({2-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 40nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3185((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-2-...)
Affinity DataIC50: 40nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
Displayed 1 to 50 (of 205 total ) | Next | Last >>
Jump to: